Oxidized albumin in blood reflects the severity of multiple vascular complications in diabetes mellitus.

Diabetic complication HNA% Nephropathy Neuropathy Oxidative stress Retinopathy

Journal

Metabolism open
ISSN: 2589-9368
Titre abrégé: Metabol Open
Pays: England
ID NLM: 101767753

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 09 01 2020
revised: 03 03 2020
accepted: 10 03 2020
entrez: 20 8 2020
pubmed: 20 8 2020
medline: 20 8 2020
Statut: epublish

Résumé

Albumin has an oxidized form, known as non-mercaptalbumin (HNA), which reflects systemic oxidative stress. The association between serum HNA levels and diabetic complications are yet to be reported. In this cross-sectional study, we investigated 164 diabetic subjects to assess the correlation between HNA% (the proportion in the total albumin) and various clinical parameters. HNA% was significantly associated with the severity of multiple complications including neuropathy (23.3 ± 4.1% vs 26.2 ± 5.1%) and nephropathy (24.1 ± 3.9%, 24.6 ± 4.2%, 28.5 ± 6.1%, 31.3 ± 5.7%, 37.8 ± 2.9%, stage 1/2/3/4/5, respectively). These findings highlight the universal importance of oxidative stress, indicating HNA% potential as a versatile marker of the severity of diabetic complications.

Identifiants

pubmed: 32812907
doi: 10.1016/j.metop.2020.100032
pii: S2589-9368(20)30012-8
pii: 100032
pmc: PMC7424782
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100032

Informations de copyright

© 2020 The Authors.

Références

Diabetes Care. 2001 Apr;24(4):775-8
pubmed: 11315848
Diabetes. 2018 May;67(5):785-790
pubmed: 29678824
Arch Ophthalmol. 1965 Dec;74(6):741-51
pubmed: 5846553
Redox Biol. 2013 Oct 08;1:483-91
pubmed: 24251116
Ther Apher Dial. 2011 Apr;15(2):156-60
pubmed: 21426508
J Exp Med. 2008 Sep 29;205(10):2409-17
pubmed: 18809715
Diabetes Res Clin Pract. 2007 Sep;77(3):420-6
pubmed: 17331614
Clin Biochem. 2016 Feb;49(3):225-31
pubmed: 26506116
Diabetes Care. 2017 Mar;40(3):412-418
pubmed: 28223445
JAMA. 2006 Apr 12;295(14):1681-7
pubmed: 16609090
Intern Med. 2012;51(11):1315-21
pubmed: 22687835
Biochem Biophys Res Commun. 2005 Sep 9;334(4):1322-8
pubmed: 16054887
Clin Chim Acta. 2014 Jun 10;433:96-104
pubmed: 24631132
Pract Lab Med. 2019 Sep 12;17:e00132
pubmed: 31649984
PLoS One. 2012;7(9):e46517
pubmed: 23029543
Nutrition. 2004 Apr;20(4):351-7
pubmed: 15043850
Diabetes Res Clin Pract. 1999 Sep;45(2-3):161-8
pubmed: 10588369
Diabetologia. 1996 Nov;39(11):1377-84
pubmed: 8933008
Diabetes Res Clin Pract. 1992 Dec;18(3):153-8
pubmed: 1289016
Nature. 2000 Apr 13;404(6779):787-90
pubmed: 10783895
Ann Clin Biochem. 2018 Jan;55(1):121-127
pubmed: 28114791
PLoS One. 2014 Jan 08;9(1):e85216
pubmed: 24416365
Biochim Biophys Acta. 2013 Dec;1830(12):5473-9
pubmed: 23618696
J Hepatol. 2013 Nov;59(5):978-83
pubmed: 23811308
Endocr J. 2010;57(2):135-40
pubmed: 19926921
Diabetes Metab Res Rev. 2010 Oct;26(7):550-8
pubmed: 20818804
Diabetes Care. 2017 Dec;40(12):1771-1778
pubmed: 29061564
Biochim Biophys Acta. 2013 Dec;1830(12):5465-72
pubmed: 23644037
Diabetes. 2008 May;57(5):1349-54
pubmed: 18299315
N Engl J Med. 2008 Feb 7;358(6):580-91
pubmed: 18256393
Metabolism. 2020 Feb;103:153995
pubmed: 31672444
J Diabetes Investig. 2015 Mar;6(2):242-6
pubmed: 25802733
Diabetes Care. 2003 May;26(5):1507-12
pubmed: 12716813
Diabetes. 2006 Jun;55(6):1832-9
pubmed: 16731850
Diab Vasc Dis Res. 2013 May;10(3):239-45
pubmed: 23091285
Clin Sci (Lond). 2015 Jul;129(2):199-216
pubmed: 25927680

Auteurs

Yuka Kobayashi (Y)

Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Ryo Suzuki (R)

Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Department of Diabetes, Metabolism and Endocrinololy, Tokyo Medical University, Tokyo, Japan.

Keiko Yasukawa (K)

Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.

Koji Oba (K)

Graduate School of Interdisciplinary Information Studies, Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Toshimasa Yamauchi (T)

Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Yutaka Yatomi (Y)

Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.

Takashi Kadowaki (T)

Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Classifications MeSH